What is the best treatment for hormonal acne?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Best Treatment for Hormonal Acne

For hormonal acne, combined oral contraceptives (COCs) containing drospirenone are the first-line treatment option for women who also desire contraception, while spironolactone is the preferred treatment for women who do not need contraception. 1, 2

First-Line Treatment Options

Combined Oral Contraceptives (COCs)

  • FDA-approved COCs for acne treatment include:

    • Drospirenone-containing pills (e.g., Yaz/Yasmin) - strongest antiandrogenic properties 2, 3, 4
    • Norgestimate-containing pills (e.g., Ortho Tri-Cyclen) 2, 3
    • Norethindrone acetate-containing pills (e.g., Estrostep Fe) 2, 3
  • Mechanism of action:

    • Decrease ovarian androgen production 2
    • Increase sex hormone-binding globulin, reducing free testosterone 2
    • Reduce 5α-reductase activity 2
    • Block androgen receptor activation 2
  • Clinical considerations:

    • Acne improvement typically takes 3-6 months 1
    • Can be used alone or in combination with other acne treatments 1
    • Beneficial for women with or without clinical signs of hyperandrogenism 1

Spironolactone

  • Mechanism: Aldosterone receptor antagonist with potent antiandrogen activity 1

  • Dosage: 50-100 mg daily is effective with favorable tolerability 1

  • Benefits:

    • 66% of women achieve clear or markedly improved skin 1
    • Can be used as monotherapy or adjunctive therapy 1
    • Can be safely combined with drospirenone-containing COCs 1
  • Safety considerations:

    • Routine potassium monitoring not required in young, healthy women without risk factors for hyperkalemia 1
    • Has black box warning due to animal studies, but multiple large cohort studies have not confirmed increased cancer risk in clinical practice 1

Treatment Algorithm

For Women Desiring Contraception:

  1. First choice: Drospirenone-containing COC (e.g., Yaz/Yasmin) 2, 3
  2. Alternative options:
    • Norgestimate-containing COC (e.g., Ortho Tri-Cyclen) 2, 3
    • Norethindrone acetate-containing COC (e.g., Estrostep Fe) 2, 3
  3. For inadequate response after 3-6 months: Add spironolactone 50-100 mg daily 1

For Women Not Desiring Contraception:

  1. First choice: Spironolactone 50-100 mg daily 1
  2. For inadequate response: Consider adding topical treatments (retinoids, benzoyl peroxide) 1

Topical Treatment Options

  • Can be used as adjuncts to hormonal therapy:
    • Topical retinoids (adapalene, tretinoin) 1
    • Benzoyl peroxide 1
    • Fixed-dose combinations of retinoids with benzoyl peroxide 1
    • Clascoterone (topical antiandrogen) 1

Important Safety Considerations

COC Contraindications:

  • History of deep vein thrombosis or pulmonary embolism 2, 4
  • Uncontrolled hypertension 4
  • Smoking in women over 35 years 4
  • Current breast cancer 4
  • Severe liver disease 4
  • Migraine with aura 2, 4

Venous Thromboembolism (VTE) Risk:

  • Baseline risk (non-pregnant, non-COC users): 1-5 per 10,000 woman-years 2
  • Risk with standard COCs: 3-9 per 10,000 woman-years 2
  • Risk with drospirenone-containing COCs: approximately 10 per 10,000 woman-years 2
  • For context, pregnancy VTE risk: 5-20 per 10,000 woman-years 2

Common Pitfalls to Avoid:

  • Avoid progestin-only contraceptives as they may worsen acne 1, 2
  • Don't expect immediate results with hormonal therapy; improvement takes 3-6 months 1
  • Don't withhold COCs from appropriate candidates due to misconceptions about antibiotic interactions - only rifampin and griseofulvin reduce COC effectiveness 1
  • Don't routinely monitor potassium in young, healthy women on spironolactone without risk factors for hyperkalemia 1

Monitoring and Follow-up

  • For COCs: Blood pressure measurement before initiation 1, 2
  • For spironolactone: Consider potassium monitoring only in patients with risk factors for hyperkalemia (renal insufficiency, heart failure, concomitant medications like ACE inhibitors) 1
  • Follow-up at 3 months to assess initial response and side effects 1
  • Assess for maximal benefit at 6 months 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Best Birth Control for Acne

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Hormonal OCPs with Antiandrogenic Effects

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.